PRESS RELEASE published on 12/04/2025 at 20:15, 1 month 10 days ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025 Galimedix Therapeutics presents compelling Phase 1 study results at CTAD 2025, demonstrating excellent safety and pharmacokinetics of GAL-101, planning Phase 2 study in Alzheimer's disease Alzheimer's Disease Galimedix Therapeutics GAL-101 Phase 1 Study CTAD 2025
PRESS RELEASE published on 12/04/2025 at 19:30, 1 month 10 days ago SMX: How a Single Counterfeit Bar Could Trigger a Multibillion-Dollar Panic SMX introduces molecular identity technology to enhance gold market security, eliminate counterfeits, and ensure trustworthy bullion authentication amidst global uncertainties Gold Market SMX Counterfeits Molecular Identity Technology Bullion Authentication
PRESS RELEASE published on 12/04/2025 at 19:13, 1 month 10 days ago Inside Information / Other news releases Press release regarding the number of outstanding shares and voting rights of a Société Anonyme in Paris as of November 30, 2025 Voting Rights Société Anonyme Outstanding Shares Paris General Meeting
PRESS RELEASE published on 12/04/2025 at 19:10, 1 month 10 days ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance SCHOTT Pharma's preliminary results for fiscal year 2025 show revenue growth and increased EBITDA margin. Outlook for FY 2026 includes moderate revenue growth and mid-term guidance updates towards 30% EBITDA margin by 2029 Revenue Growth EBITDA Margin SCHOTT Pharma Fiscal Year 2025 Mid-term Guidance
PRESS RELEASE published on 12/04/2025 at 18:53, 1 month 10 days ago EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: Outlook for fiscal year 2026 and update of mid-term guidance SCHOTT Pharma AG & Co. KGaA issues fiscal year 2026 outlook and updates mid-term guidance, projecting revenue growth of 2-5% and EBITDA margin around 27%. Market expectations differ Revenue Growth Financial Guidance EBITDA Margin SCHOTT Pharma Fiscal Year 2026
PRESS RELEASE published on 12/04/2025 at 18:50, 1 month 10 days ago Start-up of the first deep well dedicated to Natural Hydrogen EUR 8.8m in funding grants secured for the project Start-up of the first deep well dedicated to Natural Hydrogen by FDE in Moselle, France, under REGALOR II program supported by Grand Est Region and EU, securing €8.8m grants EU Funding FDE Natural Hydrogen Grand Est Region REGALOR II
PRESS RELEASE published on 12/04/2025 at 18:35, 1 month 10 days ago Showroomprivé announces the signing of an agreement to sell The Bradery Showroomprivé announces the sale of its stake in Symmetric SAS, owner of The Bradery brand, to its two executives. Payment upon closing, vendor loan, and transaction details included Sale Transaction Showroomprivé The Bradery Symmetric SAS
PRESS RELEASE published on 12/04/2025 at 18:30, 1 month 10 days ago Total number of shares and voting rights at November 30, 2025 Orange provides information on total shares, voting rights, and double voting rights for shareholders in compliance with French Commercial Code regulations Voting Rights French Commercial Code Shares Orange Double Voting Rights
PRESS RELEASE published on 12/04/2025 at 18:24, 1 month 10 days ago POS-Transaction in Own Shares Funding Circle Holdings plc has purchased 60,281 Ordinary Shares from Investec Bank plc, with a volume weighted average price of 124.7019p per share, holding a total of 1,667,954 shares in treasury London Stock Exchange Ordinary Shares Treasury Shares Funding Circle Holdings PLC Investec Bank Plc
PRESS RELEASE published on 12/04/2025 at 18:21, 1 month 10 days ago Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces the purchase of 1,296 'A' Ordinary Shares as part of its share buyback programme London Stock Exchange Share Buyback Programme Fuller Smith Turner PLC Own Shares Transaction
Published on 01/15/2026 at 03:50, 1 hour 29 minutes ago Zimtu Capital Corp. – Early Warning News Release
Published on 01/15/2026 at 03:15, 2 hours 4 minutes ago GEC(R) Langara Receives Approval for 26-Storey Flagship Project
Published on 01/15/2026 at 02:00, 3 hours 19 minutes ago Green Bridge Announces Non-Brokered Private Placement for Gross Proceeds of up to C$4 Million
Published on 01/15/2026 at 01:25, 3 hours 54 minutes ago Reeflex Solutions Inc. Provides Bi-Weekly Status Update on MCTO
Published on 01/15/2026 at 00:45, 4 hours 34 minutes ago Future Fuels Completes Gravity Survey At Hornby; Multiple Priority Anomalies Identified; Marketing Update
Published on 01/14/2026 at 20:31, 8 hours 48 minutes ago Anemoi International Ltd: Holdings in Company
Published on 01/14/2026 at 18:58, 10 hours 20 minutes ago PNE streamlines project pipeline after a successful year in terms of operations
Published on 01/14/2026 at 18:45, 10 hours 34 minutes ago Alfasigma Secures Exclusive Rights from Innovative Molecules to Parenteral Adibelivir for Treatment of HSV Encephalitis, an Ultra-Rare Disease
Published on 01/14/2026 at 18:15, 11 hours 4 minutes ago CPI PROPERTY GROUP – Results of the Share Buy-back Offer
Published on 01/14/2026 at 08:45, 20 hours 34 minutes ago Arnaud Lagardère appointed Non-Executive Chairman of Lagardère Travel Retail. Frédéric Chevalier succeeds Dag Rasmussen from March 1st 2026
Published on 01/14/2026 at 08:45, 20 hours 34 minutes ago Arnaud Lagardère appointed Non-Executive Chairman of Lagardère Travel Retail. Frédéric Chevalier succeeds Dag Rasmussen from March 1st, 2026
Published on 01/13/2026 at 17:45, 1 day 11 hours ago ENGIE Secures Its First Hybrid Solar & Storage Project in India
Published on 01/13/2026 at 17:45, 1 day 11 hours ago Half-year liquidity contract statement December 31, 2025